Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

April 15, 2020

Presentation

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Stenting

Presenter: Gilles Montalescot

April 11, 2014

Presentation

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Presenter: C.W. Lee

October 10, 2013

Presentation

Systematic Review of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis

Presenter: Tarun W. Dasari

August 21, 2013

Presentation

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Presenter: K. Tandjung

April 26, 2013

Presentation

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

Presenter: S. Deftereos

April 17, 2013

Presentation

ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Presenter: Gregg W. Stone

March 26, 2013

Presentation

Long-term Clinical Follow-up of Immunosuppressive Therapy with Oral Prednisone for the Prevention of Restenosis After PCI

Presenter: Flavio Ribichini

March 21, 2013

Presentation

RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Presenter: B-K Kim

September 19, 2012

Presentation

Double Antiplatelet Therapy After DES Implantation

Presenter: I. Ferreira-Gonz?lez

September 19, 2012

Presentation

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Presenter: Ryota Sakurai

July 12, 2012

Presentation

Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation

Presenter: T. Tada

June 01, 2012

Presentation ACC 2012

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Presenter: Myeong-Ki Hong

March 25, 2012

Presentation ACC 2012

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 24, 2012

Presentation TCT 2012

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

Presenter: Michael Werk, Thomas Albrecht, Dirk R. Meyer, Heiner Stiepani, Beatrix Schnorr, Enrique Lopez H?nninen

January 03, 2012

Advertisement

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Stenting

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Systematic Review of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Long-term Clinical Follow-up of Immunosuppressive Therapy with Oral Prednisone for the Prevention of Restenosis After PCI

RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Double Antiplatelet Therapy After DES Implantation

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content